已收盤 11-20 16:00:00 美东时间
-0.270
-2.40%
UiPath has seen its share price fall sharply in recent years, which puts fresh attention on a simple question for you as an investor. Given that drop, is today’s UiPath stock price actually justified by the earnings the business is generating? Over the past 5 years the share price has declined 77.2%, which puts the focus squarely on whether the current valuation still lines up with UiPath’s earnings power. The new partnership with Google Cloud’s
11-21 06:10
On CNBC’s “Mad Money Lightning Round,” Jim Cramer said UiPath Inc. (NYSE:PATH) is a “cheap, cheap stock, but it has no catalyst, so I have to vote it off the island.” UiPath said it will report third-quarter fiscal 2027 financial results after the closing bell on Thursday, Dec. 3. Karman Holdings In...
11-20 20:52
Lucidity recently launched the AI Action Engine, an innovative tool aimed at optimizing cloud cost management and resource utilization. Unveiled at Microsoft Ignite, the engine leverages AI agents to identify and implement cloud savings more effectively than traditional FinOps tools by closing the gap between savings recommendations and actual implementation. It autonomously identifies savings opportunities, validates them, and executes changes w
11-20 20:07
As October begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 39 stocks with short interest above 20% of...
10-05 21:35
Samsara (IOT) was in focus on Monday as Jefferies started coverage on the tech firm with a Buy rating and a $50 price target. Shares were little changed in premarket trading. "IOT serves as a system o...
10-05 19:48
UiPath, Inc. (NYSE:PATH) shares are up by about half a percent during Wednesday’s premarket session. On Tuesday, the company expanded its partnership with BDO USA to develop AI and business orchestration solutions for key enterprise functions. It includes risk management, controls transformation, en...
09-30 19:47
今日重点评级关注:HC Wainwright & Co.:维持NeuroSense Therapeutics"买入"评级,目标价从8美元升至52美元;HC Wainwright & Co.:维持艾切托"买入"评级,目标价从27美元升至34美元
09-29 08:33
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Deutsche Bank analyst Steve Powers downgraded PepsiCo Inc (NASDAQ:PEP) from Buy to Hold and cut t...
09-29 01:47
UiPath Inc. (NYSE:PATH) stock fell on Monday after DA Davidson downgraded the company to Underperform and set a $10 price target. The downgrade follows several price forecast cuts from Wall Street brokerages since the company’s Investor Day on Sept. 22. The Nasdaq is down 1.18% while the S&P 500 has...
09-28 23:58